4//SEC Filing
Gadot Harel 4
Accession 0001493152-25-005407
CIK 0000883975other
Filed
Feb 6, 7:00 PM ET
Accepted
Feb 7, 4:30 PM ET
Size
8.5 KB
Accession
0001493152-25-005407
Insider Transaction Report
Form 4
Gadot Harel
DirectorChairman, President and CEO
Transactions
- Award
Stock Option (Right to Buy)
2025-02-05+228,000→ 228,000 totalExercise: $2.04Exp: 2035-02-05→ Common Stock, par value $0.01 per share (228,000 underlying) - Award
Stock Option (Right to Buy)
2024-02-26+12,000→ 12,000 totalExercise: $1.25From: 2025-02-05Exp: 2034-02-26→ Common Stock, par value $0.01 per share (12,000 underlying)
Footnotes (2)
- [F1]The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan (the "Plan"): (a) on August 5, 2025, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock, subject to acceleration pursuant to the terms of the Plan.
- [F2]Such options, granted on February 26, 2024, were performance-based options the vesting of which was subject to the satisfaction of milestones. On February 5, 2025, the Compensation Committee of the Board of Directors of the Issuer confirmed and determined that the milestones with respect to 12,000 options have been met and, accordingly, vested.
Documents
Issuer
Microbot Medical Inc.
CIK 0000883975
Entity typeother
Related Parties
1- filerCIK 0001690103
Filing Metadata
- Form type
- 4
- Filed
- Feb 6, 7:00 PM ET
- Accepted
- Feb 7, 4:30 PM ET
- Size
- 8.5 KB